Most of the post-renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti-proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post-renal transplant patients with severe COVID-19 infection admitted to the intensive care unit.
Keywords: COVID‐19 infection; acute kidney injury; end‐stage renal disease; hypertension; immunosuppression; renal transplant.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.